H. LUNDBECK A/S

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 158106
 
  
 
C07D HETEROCYCLIC COMPOUNDS 13255
 
  
 
C07K PEPTIDES 18118
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 15191
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 12155
 
  
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 11127
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 891
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 689
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 643
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 6119

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0071,254 METHODS OF TREATING DEMENTIA AND PHARMACEUTICAL COMPOSITIONS THEREOFSep 06, 17Mar 15, 18[A61K]
2018/0065,984 Manufacture of 4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-olMar 22, 16Mar 08, 18[C07D, C07C]
2017/0326,107 5-HT6 Receptor Antagonists for Use in the Treatment of Alzheimer's Disease with Apathy as ComorbiityMay 05, 17Nov 16, 17[A61K]
2017/0318,057 Modulation of the VPS10P-Domain Receptors for the Treatment of Cardiovascular DiseaseJul 11, 17Nov 02, 17[H04L]
2017/0291,901 1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones as PDE1 InhibitorsApr 06, 17Oct 12, 17[C07D]
2017/0267,761 Agents, Uses and Methods for TreatmentJul 12, 16Sep 21, 17[C07K]
2017/0240,611 Modulation of the VPS10p-Domain Receptor Family for the Treatment of Mental and Behavioural DisordersMay 02, 17Aug 24, 17[A61K, G01N, C07K]
2017/0217,950 Bicyclo[3.2.1]Octyl Amide Derivatives and Uses of SameApr 18, 17Aug 03, 17[C07D]
2017/0158,766 Modulation of Activity of NeurotrophinsFeb 15, 17Jun 08, 17[C07K]
2017/0128,460 Cyclic AminesJan 25, 17May 11, 17[A61K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9913839 Dosing regimens for fast onset of antidepressant effectSep 13, 17Mar 13, 18[A61K]
9889122 Positive allosteric modulators of nicotinic acetylcholine receptorDec 06, 16Feb 13, 18[A61K, C07D]
9861630 activity for the treatment of cognitive impairmentAug 10, 17Jan 09, 18[A61K, C07D]
9861639 Cyclic aminesJan 25, 17Jan 09, 18[A61K]
9850249 PDE9 inhibitors with imidazo triazinone backboneNov 22, 16Dec 26, 17[A61K, C07D]
9820984 Dosing regimens for fast onset of antidepressant effectJun 28, 17Nov 21, 17[A61K]
9801878 Quinoline derivatives as PDE10A enzyme inhibitorsNov 13, 15Oct 31, 17[A61K, C07D]
9789085 Methods of treating dementia and pharmaceutical compositions thereofJun 28, 16Oct 17, 17[A61K]
9744166 activityFeb 12, 16Aug 29, 17[A61K]
9725458 Nalmefene salts as medicaments for reducing alcohol consumption or for preventing excessive alcohol consumptionJul 10, 14Aug 08, 17[A61K, C07D]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0051,268 NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS FOR TREATING OF STROKEAbandonedMar 24, 16Feb 23, 17[A61K, C12N]
2016/0326,154 BICARBOCYCLIC AND TRICARBOCYCLIC ETHYNYL DERIVATIVES AND USES OF SAMEAbandonedDec 11, 15Nov 10, 16[C07D]
2016/0318,939 Imidazopyrazinones as PDE1 InhibitorsAbandonedApr 29, 16Nov 03, 16[C07D]
2016/0311,831 Imidazotriazinones as PDE1 InhibitorsAbandonedApr 20, 16Oct 27, 16[C07D]
2016/0158,211 Dosage and Use of an A2A AntagonistAbandonedDec 01, 15Jun 09, 16[A61K]
2015/0315,130 New positive allosteric modulators of nicotinic acetylcholine receptorAbandonedDec 09, 13Nov 05, 15[C07C]
2015/0299,304 Modulation of the VPS10P-Domain Receptors for the Treatment of Cardiovascular DiseaseAbandonedJun 12, 15Oct 22, 15[C07K]
2015/0245,800 Method for Detection Of An Abnormal Sleep Pattern In A PersonAbandonedAug 20, 13Sep 03, 15[A61B]
2015/0239,973 Modulation of the Interaction Between SorLA and GDNF-Family Ligand ReceptorsAbandonedApr 08, 15Aug 27, 15[C07K]
2015/0175,584 Quinazolin-THF-amines as PDE1 inhibitorsAbandonedDec 18, 14Jun 25, 15[C07D]
2015/0080,671 Sleep Spindles as Biomarker for Early Detection of Neurodegenerative DisordersAbandonedMay 29, 14Mar 19, 15[A61B]
2014/0314,736 NOVEL PATIENT SUBGROUPS FOR THROMBOLYSISAbandonedFeb 14, 14Oct 23, 14[A61K]
2014/0315,901 Arylpyrrolopyridine derived compounds as LRRK2 inhibitorsAbandonedApr 17, 14Oct 23, 14[C07D]
2014/0199,287 NON-NEUROTOXIC PLASMINOGEN ACTIVATING FACTORS FOR TREATING OF STROKEAbandonedJan 09, 14Jul 17, 14[A61K]
2014/0155,608 METHOD FOR THE MANUFACTURING OF NALTREXONEAbandonedMay 02, 13Jun 05, 14[C07D]
2014/0038,955 HETEROARYL AMIDE ANALOGUES AS P2X7 ANTAGONISTSAbandonedOct 02, 13Feb 06, 14[C07D]
8633190 Spirolactam derivatives and uses of sameExpiredOct 26, 10Jan 21, 14[A61K, C07D]
2014/0005,216 Nalmefene for reduction of alcohol consumption in specific target populationsAbandonedJun 26, 13Jan 02, 14[A61K]
2014/0005,217 Nalmefene for reduction of alcohol consumption in specific target populationsAbandonedJun 26, 13Jan 02, 14[A61K]
2013/0331,575 Method for resolution of 4-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-1,2,2-trimethyl-piperazine and 1-((1R,3S)-6-chloro-3-phenyl-indan-1-yl)-3,3-dimethyl-piperazineAbandonedJan 06, 12Dec 12, 13[C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.